Chlorotrianisene

This classification denotes a non-steroidal estrogen with the molecular formula C23H21ClO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6V5034L121, chemically known as 1,1,1-(1-chloro-1-ethenyl-2-ylidene)-tris(4-methoxybenzene) but generally known as chlorotrianisene, which bears US NIH Compound Identifier 11289. European Medicines Agency schedules Chlorotrianisene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06199MIG. The term CHLOROTRIANISENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules chlorotrianisene in its Anatomical Therapeutic Chemical (ATC) Classification. CHLOROTRIANISENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorotrianisene under HS 29093090 and SITC 51616. As of Q4 2014, CHLOROTRIANISENE remains the US FDA Preferred Term for this commodity. Chlorotrianisene bears US NLM identifiers UMLS ID C0008275 and NCI Concept Code C65320. SMILES: Cl/C(=C(\c1ccc(OC)cc1)c1ccc(OC)cc1)c1ccc(OC)cc1.